Eagle Capital Growth Fund Inc

GRF
9,53
0,00 (0,00%)
28 Mar 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/3/202417:11EDGAR2Form DEF 14A - Other definitive proxy statements
06/3/202418:56EDGAR2Form N-CSR - Certified Shareholder Report
28/2/202417:20EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
23/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202409:16GLOBEGrifols announces positive topline phase 3 fibrinogen..
13/2/202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202421:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202314:00GLOBEGrifols Completes Cohort 1 in Clinical Study of Alpha-1 15%,..
07/11/202322:45EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
06/11/202314:00GLOBEGigaGen Presents IND-Enabling Data and Phase 1 Trial..
25/10/202300:30GLOBEAraclon Biotech Presents Positive Final Results from Phase 2..
13/10/202323:30BWEagle Capital Growth Fund Declares Year-End Distribution of..
02/10/202320:30EDGAR2Form SC 13D - General statement of acquisition of beneficial..
02/10/202320:16EDGAR2Form SC 13D/A - General statement of acquisition of..
30/8/202321:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202321:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202321:45EDGAR2Form N-CSRS - Certified Shareholder Report, Semi-Annual
01/8/202314:00GLOBEGrifols Accelerates Healthcare Innovation with Google..
18/4/202316:30PRNUSGrifols 2022 Annual Report on Form 20-F filed with the SEC..
Apertura: 9,53 Min: 9,53 Max: 9,53
Chiusura: 9,53

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network